Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Programs
- Genome Technology Program3
- Impact of Genomic Variation on Function (IGVF) Consortium2
- Encyclopedia of DNA Elements (ENCODE) Project1
- NHGRI Genomic Data Science Analysis, Visualization and Informatics Lab-space (AnVIL)2
- Genomics Research to Elucidate the Genetics of Rare Diseases (GREGOR) Consortium2
- Multi-Omics for Health and Disease (Multi-Omics)1
- Ethical, Legal and Social Implications (ELSI) Research Program4
- Genomics-Enabled Learning Health Systems (gLHS)1
Research Funding
NHGRI is initiating a new program-the Impact of Genomic Variation on Function (IGVF) Consortium to develop a framework for systematically understanding the effects of genomic variation on genome function and how these effects shape phenotypes.
… CRISPR screen data generated by the IGVF Consortium. Wei Li, George Washington University The Li lab is developing innovative computational methods to …
File
… During the FY201 3 and FY 201 4 reporting period, Dr. Rongling Li , Program Director , Division of Genomic Medicine , overs …
Policies and Guidance
This page provides an overview of Resource Sharing Plans, a required document in most NIH funding applications. Most applicants for NIH funding must provide a Resource Sharing Plan (RSP) documenting plans for sharing resources that result from their federally funded work. NIH Policies that govern the sharing of resources include the NIH Model Organism Sharing Policy and the NIH Research Tools Policy.
Event
NHGRI and the University at Buffalo Center for Disability Studies will hold a two-day symposium on October 6-7, 2022 to address historical constructions of disability and ableism, with a focus on the “irreducibility” of individuals with disability and the history of disability.
Leadership Initiatives
The 2021 NHGRI Action Agenda for a diverse genomics workforce is an ambitious set of goals and objectives to enhance the representation individuals from diverse backgrounds including those from underrepresented groups in the genomics workforce. The Action Agenda: Progress Report and Implementation Plan details the programs and projects that have been enacted since its release.
FAQ
Frequently asked questions on the webinar for the Diversity Centers for Genome Research funding opportunity announcements (FOAs): (RFA-HG-22-026 and RFA-HG-22-027.
Fact Sheet
Gene therapy for sickle cell disease is available to you through FDA-approved therapies and through clinical trials.
FAQ
Questions and answers to help applicants responding to the ML/AI Tools to Advance Genomic Translational Research (MAGen) notice of funding opportunities (NOFOs): RFA-HG-24-004 and RFA-HG-24-005.
File
… -- of- OKLAHOMA ~ Washington Uni versi inStlouis R BROAD li.1 1NSTITUTE THE UN IVERS ITY OF ALA BAMA AT BIRMINGHAM The …
FAQ
Frequently asked questions about the annual Bettie J. Graham Leadership Award for Enhancing DEIA in the Genomics Workforce.